Spire Healthcare Shows Growing Revenue and Profits

British private healthcare group Spire on Thursday posted strong half-year results in its income statement.

Spire Healthcare reported steady growth in its half-year report, with revenues up 38.9% from the same period last year. Pre-tax profit was also up, to £ 4.7million ($ 6.5million), compared to last year’s figures when the group recorded a loss of £ 231.3million ( $ 319.7 million).

Uncertainty related to Covid-19

The group said it would review its structure and capital allocation, including its future dividend policy – no dividends have been paid since the cancellation of its final dividend in 2019, due to the uncertainty caused by Covid-19.

Spire Healthcare, which is a leading independent hospital group in the UK, in July rejected plans to buy out Australian medical group Ramsey Health Care.

“The board of directors of Spire Healthcare and its advisors have supported the proposed transaction, and it has been proposed to shareholders. The company respects the point of view of shareholders who have not provided enough voice to support the plan of arrangement and is confident that it remains well positioned to succeed as a stand-alone business, ”the statement said.

Focused future

Spire said the period of “uncertainty” is behind it and has not impacted the operational performance of the company.

“We remain focused on our goal of making a positive difference in the lives of patients through exceptional personalized care,” the statement said.

Speyer stock was up 0.21% to 237p in the early hours of London today.

Read more: Spire Healthcare shareholders reject £ 1bn takeover bid from Australian rival Ramsey

Ready to start?

Download

Capital Com is an execution-only service provider. The material provided on this website is for informational purposes only and should not be construed as investment advice. Any opinion that may be provided on this page does not constitute a recommendation of Capital Com or its agents. We make no representations or warranties about the accuracy or completeness of the information provided on this page. If you rely on the information on this page, you do so entirely at your own risk.

Source link

About Catriona

Catriona

Check Also

Is Legal & General Group Plc (LON: LGEN) a high quality share to own?

While some investors are already familiar with financial metrics (hat tip), this article is for …

Leave a Reply

Your email address will not be published. Required fields are marked *